Cargando…

Correlation of Different Serum Biomarkers with Prediction of Early Pancreatic Graft Dysfunction Following Simultaneous Pancreas and Kidney Transplantation

Background: Despite recent advances and refinements in perioperative management of simultaneous pancreas–kidney transplantation (SPKT) early pancreatic graft dysfunction (ePGD) remains a critical problem with serious impairment of early and long-term graft function and outcome. Hence, we evaluated a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jahn, Nora, Voelker, Maria Theresa, Laudi, Sven, Stehr, Sebastian, Schneeberger, Stefan, Brandacher, Gerald, Sucher, Elisabeth, Rademacher, Sebastian, Seehofer, Daniel, Sucher, Robert, Hau, Hans Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103915/
https://www.ncbi.nlm.nih.gov/pubmed/35566689
http://dx.doi.org/10.3390/jcm11092563
_version_ 1784707666738675712
author Jahn, Nora
Voelker, Maria Theresa
Laudi, Sven
Stehr, Sebastian
Schneeberger, Stefan
Brandacher, Gerald
Sucher, Elisabeth
Rademacher, Sebastian
Seehofer, Daniel
Sucher, Robert
Hau, Hans Michael
author_facet Jahn, Nora
Voelker, Maria Theresa
Laudi, Sven
Stehr, Sebastian
Schneeberger, Stefan
Brandacher, Gerald
Sucher, Elisabeth
Rademacher, Sebastian
Seehofer, Daniel
Sucher, Robert
Hau, Hans Michael
author_sort Jahn, Nora
collection PubMed
description Background: Despite recent advances and refinements in perioperative management of simultaneous pancreas–kidney transplantation (SPKT) early pancreatic graft dysfunction (ePGD) remains a critical problem with serious impairment of early and long-term graft function and outcome. Hence, we evaluated a panel of classical blood serum markers for their value in predicting early graft dysfunction in patients undergoing SPKT. Methods: From a prospectively collected database medical data of 105 patients undergoing SPKT between 1998 and 2018 at our center were retrospectively analyzed. The primary study outcome was the detection of occurrence of early pancreatic graft dysfunction (ePGD), the secondary study outcome was early renal graft dysfunction (eRGD) as well as all other outcome parameters associated with the graft function. In this context, ePGD was defined as pancreas graft-related complications including graft pancreatitis, pancreatic abscess/peritonitis, delayed graft function, graft thrombosis, bleeding, rejection and the consecutive need for re-laparotomy due to graft-related complications within 3 months. With regard to analyzing ePGD, serum levels of white blood cell count (WBC), C-reactive protein (CRP), procalcitonin (PCT), pancreatic lipase as well as neutrophil–lymphocyte ratio (NLR) and platelet–lymphocyte ratio (PLR) were measured preoperatively and at postoperative days (POD) 1, 2, 3 and 5. Further, peak serum levels of CRP and lipase during the first 72 h were evaluated. Receiver operating characteristics (ROC) curves were performed to assess their predictive value for ePGD and eRGD. Cut-off levels were calculated with the Youden index. Significant diagnostic biochemical cut-offs as well as other prognostic clinical factors were tested in a multivariate logistic regression model. Results: Of the 105 patients included, 43 patients (41%) and 28 patients (27%) developed ePGD and eRGD following SPKT, respectively. The mean WBC, PCT, NLR, PLR, CRP and lipase levels were significantly higher on most PODs in the ePGD group compared to the non-ePGD group. ROC analysis indicated that peak lipase (AUC: 0.82) and peak CRP levels (AUC: 0.89) were highly predictive for ePGD after SPKT. The combination of both achieved the highest AUC (0.92; p < 0.01) in predicting ePGD. Concerning eRGD, predictive accuracy of all analyzed serological markers was moderate (all AUC < 0.8). Additionally, multivariable analysis identified previous dialysis/no preemptive transplantation (OR 2.4 (95% CI: 1.41–4.01), p = 0.021), donor age (OR 1.07 (95% CI: 1.03–1.14), p < 0.010), donor body mass index (OR 1.32 (95% CI: 1.01–1.072), p = 0.04), donors cerebrovascular cause of death (OR 7.8 (95% CI: 2.21–26.9), p < 0.010), donor length of ICU stay (OR 1.27 (95% CI: 1.08–1.49), p < 0.010), as well as CIT pancreas (OR 1.07 (95% CI: 1.03–1.14), p < 0.010) as clinical relevant prognostic predictors for ePGD. Further, a peak of lipase (OR 1.04 (95% CI: 1.02–1.07), p < 0.010), peak of CRP levels (OR 1.12 (95% CI: 1.02–1.23), p < 0.010), pancreatic serum lipase concentration on POD 2 > 150 IU/L (OR 2.9 (95% CI: 1.2–7.13), p = 0.021) and CRP levels of ≥ 180 ng/mL on POD 2 (OR 3.6 (95% CI: 1.54–8.34), p < 0.01) and CRP levels > 150 ng/mL on POD 3 (OR 4.5 (95% CI: 1.7–11.4), p < 0.01) were revealed as independent biochemical predictive variables for ePGD after transplantation. Conclusions: In the current study, the combination of peak lipase and CRP levels were highly effective in predicting early pancreatic graft dysfunction development following SPKT. In contrast, for early renal graft dysfunction the predictive value of this parameter was less sensitive. Intensified monitoring of these parameters may be helpful for identifying patients at a higher risk of pancreatic ischemia reperfusion injury and various IRI- associated postoperative complications leading to ePGD and thus deteriorated outcome.
format Online
Article
Text
id pubmed-9103915
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91039152022-05-14 Correlation of Different Serum Biomarkers with Prediction of Early Pancreatic Graft Dysfunction Following Simultaneous Pancreas and Kidney Transplantation Jahn, Nora Voelker, Maria Theresa Laudi, Sven Stehr, Sebastian Schneeberger, Stefan Brandacher, Gerald Sucher, Elisabeth Rademacher, Sebastian Seehofer, Daniel Sucher, Robert Hau, Hans Michael J Clin Med Article Background: Despite recent advances and refinements in perioperative management of simultaneous pancreas–kidney transplantation (SPKT) early pancreatic graft dysfunction (ePGD) remains a critical problem with serious impairment of early and long-term graft function and outcome. Hence, we evaluated a panel of classical blood serum markers for their value in predicting early graft dysfunction in patients undergoing SPKT. Methods: From a prospectively collected database medical data of 105 patients undergoing SPKT between 1998 and 2018 at our center were retrospectively analyzed. The primary study outcome was the detection of occurrence of early pancreatic graft dysfunction (ePGD), the secondary study outcome was early renal graft dysfunction (eRGD) as well as all other outcome parameters associated with the graft function. In this context, ePGD was defined as pancreas graft-related complications including graft pancreatitis, pancreatic abscess/peritonitis, delayed graft function, graft thrombosis, bleeding, rejection and the consecutive need for re-laparotomy due to graft-related complications within 3 months. With regard to analyzing ePGD, serum levels of white blood cell count (WBC), C-reactive protein (CRP), procalcitonin (PCT), pancreatic lipase as well as neutrophil–lymphocyte ratio (NLR) and platelet–lymphocyte ratio (PLR) were measured preoperatively and at postoperative days (POD) 1, 2, 3 and 5. Further, peak serum levels of CRP and lipase during the first 72 h were evaluated. Receiver operating characteristics (ROC) curves were performed to assess their predictive value for ePGD and eRGD. Cut-off levels were calculated with the Youden index. Significant diagnostic biochemical cut-offs as well as other prognostic clinical factors were tested in a multivariate logistic regression model. Results: Of the 105 patients included, 43 patients (41%) and 28 patients (27%) developed ePGD and eRGD following SPKT, respectively. The mean WBC, PCT, NLR, PLR, CRP and lipase levels were significantly higher on most PODs in the ePGD group compared to the non-ePGD group. ROC analysis indicated that peak lipase (AUC: 0.82) and peak CRP levels (AUC: 0.89) were highly predictive for ePGD after SPKT. The combination of both achieved the highest AUC (0.92; p < 0.01) in predicting ePGD. Concerning eRGD, predictive accuracy of all analyzed serological markers was moderate (all AUC < 0.8). Additionally, multivariable analysis identified previous dialysis/no preemptive transplantation (OR 2.4 (95% CI: 1.41–4.01), p = 0.021), donor age (OR 1.07 (95% CI: 1.03–1.14), p < 0.010), donor body mass index (OR 1.32 (95% CI: 1.01–1.072), p = 0.04), donors cerebrovascular cause of death (OR 7.8 (95% CI: 2.21–26.9), p < 0.010), donor length of ICU stay (OR 1.27 (95% CI: 1.08–1.49), p < 0.010), as well as CIT pancreas (OR 1.07 (95% CI: 1.03–1.14), p < 0.010) as clinical relevant prognostic predictors for ePGD. Further, a peak of lipase (OR 1.04 (95% CI: 1.02–1.07), p < 0.010), peak of CRP levels (OR 1.12 (95% CI: 1.02–1.23), p < 0.010), pancreatic serum lipase concentration on POD 2 > 150 IU/L (OR 2.9 (95% CI: 1.2–7.13), p = 0.021) and CRP levels of ≥ 180 ng/mL on POD 2 (OR 3.6 (95% CI: 1.54–8.34), p < 0.01) and CRP levels > 150 ng/mL on POD 3 (OR 4.5 (95% CI: 1.7–11.4), p < 0.01) were revealed as independent biochemical predictive variables for ePGD after transplantation. Conclusions: In the current study, the combination of peak lipase and CRP levels were highly effective in predicting early pancreatic graft dysfunction development following SPKT. In contrast, for early renal graft dysfunction the predictive value of this parameter was less sensitive. Intensified monitoring of these parameters may be helpful for identifying patients at a higher risk of pancreatic ischemia reperfusion injury and various IRI- associated postoperative complications leading to ePGD and thus deteriorated outcome. MDPI 2022-05-03 /pmc/articles/PMC9103915/ /pubmed/35566689 http://dx.doi.org/10.3390/jcm11092563 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jahn, Nora
Voelker, Maria Theresa
Laudi, Sven
Stehr, Sebastian
Schneeberger, Stefan
Brandacher, Gerald
Sucher, Elisabeth
Rademacher, Sebastian
Seehofer, Daniel
Sucher, Robert
Hau, Hans Michael
Correlation of Different Serum Biomarkers with Prediction of Early Pancreatic Graft Dysfunction Following Simultaneous Pancreas and Kidney Transplantation
title Correlation of Different Serum Biomarkers with Prediction of Early Pancreatic Graft Dysfunction Following Simultaneous Pancreas and Kidney Transplantation
title_full Correlation of Different Serum Biomarkers with Prediction of Early Pancreatic Graft Dysfunction Following Simultaneous Pancreas and Kidney Transplantation
title_fullStr Correlation of Different Serum Biomarkers with Prediction of Early Pancreatic Graft Dysfunction Following Simultaneous Pancreas and Kidney Transplantation
title_full_unstemmed Correlation of Different Serum Biomarkers with Prediction of Early Pancreatic Graft Dysfunction Following Simultaneous Pancreas and Kidney Transplantation
title_short Correlation of Different Serum Biomarkers with Prediction of Early Pancreatic Graft Dysfunction Following Simultaneous Pancreas and Kidney Transplantation
title_sort correlation of different serum biomarkers with prediction of early pancreatic graft dysfunction following simultaneous pancreas and kidney transplantation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103915/
https://www.ncbi.nlm.nih.gov/pubmed/35566689
http://dx.doi.org/10.3390/jcm11092563
work_keys_str_mv AT jahnnora correlationofdifferentserumbiomarkerswithpredictionofearlypancreaticgraftdysfunctionfollowingsimultaneouspancreasandkidneytransplantation
AT voelkermariatheresa correlationofdifferentserumbiomarkerswithpredictionofearlypancreaticgraftdysfunctionfollowingsimultaneouspancreasandkidneytransplantation
AT laudisven correlationofdifferentserumbiomarkerswithpredictionofearlypancreaticgraftdysfunctionfollowingsimultaneouspancreasandkidneytransplantation
AT stehrsebastian correlationofdifferentserumbiomarkerswithpredictionofearlypancreaticgraftdysfunctionfollowingsimultaneouspancreasandkidneytransplantation
AT schneebergerstefan correlationofdifferentserumbiomarkerswithpredictionofearlypancreaticgraftdysfunctionfollowingsimultaneouspancreasandkidneytransplantation
AT brandachergerald correlationofdifferentserumbiomarkerswithpredictionofearlypancreaticgraftdysfunctionfollowingsimultaneouspancreasandkidneytransplantation
AT sucherelisabeth correlationofdifferentserumbiomarkerswithpredictionofearlypancreaticgraftdysfunctionfollowingsimultaneouspancreasandkidneytransplantation
AT rademachersebastian correlationofdifferentserumbiomarkerswithpredictionofearlypancreaticgraftdysfunctionfollowingsimultaneouspancreasandkidneytransplantation
AT seehoferdaniel correlationofdifferentserumbiomarkerswithpredictionofearlypancreaticgraftdysfunctionfollowingsimultaneouspancreasandkidneytransplantation
AT sucherrobert correlationofdifferentserumbiomarkerswithpredictionofearlypancreaticgraftdysfunctionfollowingsimultaneouspancreasandkidneytransplantation
AT hauhansmichael correlationofdifferentserumbiomarkerswithpredictionofearlypancreaticgraftdysfunctionfollowingsimultaneouspancreasandkidneytransplantation